Using a Revenue DCF model with operating margin convergence from -0.1% to a target of 13.1% over 5 years, discounted at a WACC of 7.7%, The Chemours Company (CC) has an intrinsic value of $29.94 per share (range: $2.76 – $126.00).
Using a Revenue DCF model with operating margin convergence from -0.1% to a target of 13.1% over 5 years, discounted at a WACC of 7.7%, The Chemours Company (CC) has an intrinsic value of $37.63 per share (range: $1.64 – $149.45).
Using the industry peer median EV/Revenue multiple (trailing + forward), The Chemours Company (CC) has a fair value of $91.10 based on 10 comparable companies in the Chemicals - Specialty industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| The Chemours CompanyCC | 3,469 | 1.3x | 1.3x |
| Linde plc | 228,136 | 7.4x | 7.0x |
| Air Products and Chemicals, Inc. | 65,782 | 6.8x | 6.5x |
| PPG Industries, Inc. | 24,280 | 1.9x | 1.9x |
| LyondellBasell Industries N.V. | 23,163 | 1.2x | 0.9x |
| International Flavors & Fragrances Inc. | 20,692 | 2.5x | 2.5x |
| Westlake Corporation | 12,473 | 1.4x | 1.3x |
| Element Solutions Inc | 10,694 | 4.6x | 4.8x |
| Axalta Coating Systems Ltd. | 6,234 | 1.8x | 1.8x |
| Sensient Technologies Corporation | 5,015 | 3.6x | 3.7x |
| Perimeter Solutions, S.A. | 4,789 | 6.9x | 8.2x |
| Industry Median | 3.0x | 3.1x | |
| (*) Revenue | 5,808 | 5,758 | |
| = Enterprise Value | 17,504 | 17,751 | |
| (-) Net Debt | 3,913 | 3,913 | |
| Equity Value | 13,591 | 13,838 | |
| (/) Outstanding shares | 151 | 151 | |
| Fair Price | $90 | $92 | |
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.